Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02155816 · ClinicalTrials.gov registry record · NA
Omega 7 + 3 Combination and Systemic Inflammation
A NA study, sponsored by Appalachian State University.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT02155816 is a NA study that has completed, run by Appalachian State University. The registered enrollment target is 68 participants.
The verdict
NCT02155816, a NA study, has completed, sponsored by Appalachian State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if supplementation with a mixture of omega 7 and 3 fats has a favorable influence on blood inflammation and lipoprotein biomarkers in women with systemic inflammation compared to omega 3 and placebo.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Omega 3
- DIETARY_SUPPLEMENT Omega 7 + 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2014-05 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02155816
The ClinicalTrials.gov registry entry for NCT02155816 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Appalachian State University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02155816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02155816 about?
NCT02155816 is a clinical study titled "Omega 7 + 3 Combination and Systemic Inflammation". The purpose of this study is to determine if supplementation with a mixture of omega 7 and 3 fats has a favorable influence on blood inflammation and lipoprotein biomarkers in women with systemic inflammation compared to omega 3 and placebo.
What is the current status of trial NCT02155816?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2014-05. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02155816?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Omega 3 (DIETARY_SUPPLEMENT), Omega 7 + 3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02155816?
This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.